TNP-351 is primarily utilized in the field of oncology research due to its potential as an anticancer agent. It has been studied for its ability to inhibit specific enzymes or pathways that are crucial for cancer cell proliferation and survival. Researchers are exploring its efficacy in targeting various types of cancers, particularly those resistant to conventional therapies. Additionally, TNP-351 is being investigated for its potential to enhance the effectiveness of existing chemotherapy drugs when used in combination therapies. Its application extends to preclinical studies, where it serves as a valuable tool for understanding cancer biology and developing novel treatment strategies.